ADDOPT

ADDoPT is a four-year collaboration between pharmaceutical companies, solution providers and academia. Part-funded under the Advanced Manufacturing Supply Chains Initiative (AMSCI) and supported by the Medicines Manufacturing Industry Partnership (MMIP), It aims to make existing and new Digital Design approaches widely usable within the pharmaceutical industry and thereby increase efficiency and effectiveness of drug development and manufacture... The ADDoPT (Advanced Digital Design of Pharmaceutical Therapeutics) project is addressing the pharmaceutical industry's desire to deliver medicines more effectively to patients. ADDoPT is developing and implementing advanced digital design techniques that eliminate non-viable drug candidate formulations as early as possible, streamlining design, development and manufacturing processes.

Primary location: London United Kingdom